Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Thymus Neoplasms × Cisplatin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 461 Squamous Cell Carcinoma of Head and Neck 217 Head and Neck Neoplasms 207 Lung Neoplasms 205 Uterine Cervical Neoplasms 143 Stomach Neoplasms 139 Esophageal Neoplasms 138 Nasopharyngeal Carcinoma 117 Urinary Bladder Neoplasms 97 Neoplasms 94 Esophageal Squamous Cell Carcinoma 92 Small Cell Lung Carcinoma 85 Breast Neoplasms 79 Ovarian Neoplasms 75 Neoplasm Metastasis 69 Pancreatic Neoplasms 66 Cholangiocarcinoma 63 Carcinoma, Squamous Cell 62 Biliary Tract Neoplasms 62 Mesothelioma, Malignant 52 Adenocarcinoma Of Esophagus 44 Carcinoma 43 Recurrence 41 Oropharyngeal Neoplasms 41 Carcinoma, Ovarian Epithelial 41 Parkinson Disease 4, Autosomal Dominant Lewy Body 39 Gallbladder Neoplasms 36 Adenocarcinoma of Lung 35 Lymphoma 33 Carcinoma, Transitional Cell 32

Interventions

pembrolizumab 3 Drug Therapy 2 ribociclib 1 palbociclib 1 fludarabine 1 epacadostat 1 bosutinib 1 amrubicin 1 Sunitinib 1 Radiosurgery 1 Proton Therapy 1 Plicamycin 1 Pemetrexed 1 Magnetic Resonance Spectroscopy 1 Immunotherapy 1 Fluorodeoxyglucose F18 1 FAPI-46 1 Everolimus 1 Erlotinib Hydrochloride 1 Cyclophosphamide 1 Cisplatin 1 Blood Specimen Collection 1 Bevacizumab 1 177Lu-octreotide, DOTA(0)-Tyr(3)- 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01312324 2016-04-20

Neoadjuvant Chemotherapy for Locally Advanced Thymic Cancer

Samsung Medical Center

Phase 2 Completed

Thymus Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡